{"id":5597,"date":"2012-02-26T09:00:00","date_gmt":"2012-02-26T09:00:00","guid":{"rendered":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nieuwe-c-peptide-test-verlegt-de-tijdsgrenzen-van-mogelijke-behandeling\/"},"modified":"2024-09-23T11:22:46","modified_gmt":"2024-09-23T11:22:46","slug":"nieuwe-c-peptide-test-verlegt-de-tijdsgrenzen-van-mogelijke-behandeling","status":"publish","type":"post","link":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nieuwe-c-peptide-test-verlegt-de-tijdsgrenzen-van-mogelijke-behandeling\/","title":{"rendered":"Nieuwe C-peptide test verandert idee van T1D"},"content":{"rendered":"Onderzoekers van het Massachusetts General Hospital gebruikten een nieuwe, zeer gevoelige test om C-peptide in het bloed van T1D pati\u00ebnten te meten. C-peptide komt vrij bij de productie van insuline en is een veel gebruikte indicator voor de ontwikkeling van T1D. Het blijkt dat in tegenstelling tot wat tot nu toe werd aangenomen, C-peptide ook bij gevorderde T1D nog steeds kan worden gemeten. Zelfs bij pati\u00ebnten die de ziekte al meer dan 30 jaar hadden, bleek 10% nog steeds wat C-peptide in het bloed te hebben. Dit betekent dat er nog steeds een beetje insuline wordt geproduceerd en dat er dus nog steeds levende beta cellen in de pancreas zijn. Het tijdsvenster voor therapeutische interventie kan daarom wel eens een stuk ruimer zijn dan tot nu toe werd aangenomen.\n\n<a href=\"http:\/\/diabetes.diabetesjournals.org\/content\/early\/2012\/02\/07\/db11-1197.abstract\">Lees verder (Engelstalig)<\/a>","protected":false,"raw":""},"excerpt":{"rendered":"<p>Onderzoekers van het Massachusetts General Hospital gebruikten een nieuwe, zeer gevoelige test om C-peptide in het bloed van T1D pati\u00ebnten te meten. C-peptide komt vrij bij de productie van insuline en is een veel gebruikte indicator voor de ontwikkeling van T1D. Het blijkt dat in tegenstelling tot wat tot nu toe werd aangenomen, C-peptide ook [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[184],"tags":[],"class_list":["post-5597","post","type-post","status-publish","format-standard","hentry","category-archief"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nieuwe C-peptide test verandert idee van T1D - Breakthrough T1D<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nieuwe-c-peptide-test-verlegt-de-tijdsgrenzen-van-mogelijke-behandeling\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nieuwe C-peptide test verandert idee van T1D - Breakthrough T1D\" \/>\n<meta property=\"og:description\" content=\"Onderzoekers van het Massachusetts General Hospital gebruikten een nieuwe, zeer gevoelige test om C-peptide in het bloed van T1D pati\u00ebnten te meten. C-peptide komt vrij bij de productie van insuline en is een veel gebruikte indicator voor de ontwikkeling van T1D. Het blijkt dat in tegenstelling tot wat tot nu toe werd aangenomen, C-peptide ook [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nieuwe-c-peptide-test-verlegt-de-tijdsgrenzen-van-mogelijke-behandeling\/\" \/>\n<meta property=\"og:site_name\" content=\"Breakthrough T1D\" \/>\n<meta property=\"article:published_time\" content=\"2012-02-26T09:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-23T11:22:46+00:00\" \/>\n<meta name=\"author\" content=\"ylt-admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Geschreven door\" \/>\n\t<meta name=\"twitter:data1\" content=\"ylt-admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/breakthrought1d.eu\\\/nl\\\/nieuws\\\/nieuwe-c-peptide-test-verlegt-de-tijdsgrenzen-van-mogelijke-behandeling\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/breakthrought1d.eu\\\/nl\\\/nieuws\\\/nieuwe-c-peptide-test-verlegt-de-tijdsgrenzen-van-mogelijke-behandeling\\\/\"},\"author\":{\"name\":\"ylt-admin\",\"@id\":\"https:\\\/\\\/breakthrought1d.eu\\\/nl\\\/#\\\/schema\\\/person\\\/c141fde9814deb17e9eb392bdb6619a6\"},\"headline\":\"Nieuwe C-peptide test verandert idee van T1D\",\"datePublished\":\"2012-02-26T09:00:00+00:00\",\"dateModified\":\"2024-09-23T11:22:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/breakthrought1d.eu\\\/nl\\\/nieuws\\\/nieuwe-c-peptide-test-verlegt-de-tijdsgrenzen-van-mogelijke-behandeling\\\/\"},\"wordCount\":143,\"publisher\":{\"@id\":\"https:\\\/\\\/breakthrought1d.eu\\\/nl\\\/#organization\"},\"articleSection\":[\"Archief\"],\"inLanguage\":\"nl-NL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/breakthrought1d.eu\\\/nl\\\/nieuws\\\/nieuwe-c-peptide-test-verlegt-de-tijdsgrenzen-van-mogelijke-behandeling\\\/\",\"url\":\"https:\\\/\\\/breakthrought1d.eu\\\/nl\\\/nieuws\\\/nieuwe-c-peptide-test-verlegt-de-tijdsgrenzen-van-mogelijke-behandeling\\\/\",\"name\":\"Nieuwe C-peptide test verandert idee van T1D - Breakthrough T1D\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/breakthrought1d.eu\\\/nl\\\/#website\"},\"datePublished\":\"2012-02-26T09:00:00+00:00\",\"dateModified\":\"2024-09-23T11:22:46+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/breakthrought1d.eu\\\/nl\\\/nieuws\\\/nieuwe-c-peptide-test-verlegt-de-tijdsgrenzen-van-mogelijke-behandeling\\\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/breakthrought1d.eu\\\/nl\\\/nieuws\\\/nieuwe-c-peptide-test-verlegt-de-tijdsgrenzen-van-mogelijke-behandeling\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/breakthrought1d.eu\\\/nl\\\/nieuws\\\/nieuwe-c-peptide-test-verlegt-de-tijdsgrenzen-van-mogelijke-behandeling\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/breakthrought1d.eu\\\/nl\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nieuwe C-peptide test verandert idee van T1D\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/breakthrought1d.eu\\\/nl\\\/#website\",\"url\":\"https:\\\/\\\/breakthrought1d.eu\\\/nl\\\/\",\"name\":\"Breakthrough T1D\",\"description\":\"Wij zetten ons in voor een toekomst zonder T1D\",\"publisher\":{\"@id\":\"https:\\\/\\\/breakthrought1d.eu\\\/nl\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/breakthrought1d.eu\\\/nl\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/breakthrought1d.eu\\\/nl\\\/#organization\",\"name\":\"Breakthrough T1D\",\"url\":\"https:\\\/\\\/breakthrought1d.eu\\\/nl\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/breakthrought1d.eu\\\/nl\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/breakthrought1d.eu\\\/nl\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/BTlogo.png\",\"contentUrl\":\"https:\\\/\\\/breakthrought1d.eu\\\/nl\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/BTlogo.png\",\"width\":330,\"height\":141,\"caption\":\"Breakthrough T1D\"},\"image\":{\"@id\":\"https:\\\/\\\/breakthrought1d.eu\\\/nl\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/breakthrought1d.eu\\\/nl\\\/#\\\/schema\\\/person\\\/c141fde9814deb17e9eb392bdb6619a6\",\"name\":\"ylt-admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"caption\":\"ylt-admin\"},\"sameAs\":[\"https:\\\/\\\/87.250.144.92\"],\"url\":\"https:\\\/\\\/breakthrought1d.eu\\\/nl\\\/nieuws\\\/author\\\/ylt-admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nieuwe C-peptide test verandert idee van T1D - Breakthrough T1D","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nieuwe-c-peptide-test-verlegt-de-tijdsgrenzen-van-mogelijke-behandeling\/","og_locale":"nl_NL","og_type":"article","og_title":"Nieuwe C-peptide test verandert idee van T1D - Breakthrough T1D","og_description":"Onderzoekers van het Massachusetts General Hospital gebruikten een nieuwe, zeer gevoelige test om C-peptide in het bloed van T1D pati\u00ebnten te meten. C-peptide komt vrij bij de productie van insuline en is een veel gebruikte indicator voor de ontwikkeling van T1D. Het blijkt dat in tegenstelling tot wat tot nu toe werd aangenomen, C-peptide ook [&hellip;]","og_url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nieuwe-c-peptide-test-verlegt-de-tijdsgrenzen-van-mogelijke-behandeling\/","og_site_name":"Breakthrough T1D","article_published_time":"2012-02-26T09:00:00+00:00","article_modified_time":"2024-09-23T11:22:46+00:00","author":"ylt-admin","twitter_card":"summary_large_image","twitter_misc":{"Geschreven door":"ylt-admin","Geschatte leestijd":"1 minuut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nieuwe-c-peptide-test-verlegt-de-tijdsgrenzen-van-mogelijke-behandeling\/#article","isPartOf":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nieuwe-c-peptide-test-verlegt-de-tijdsgrenzen-van-mogelijke-behandeling\/"},"author":{"name":"ylt-admin","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6"},"headline":"Nieuwe C-peptide test verandert idee van T1D","datePublished":"2012-02-26T09:00:00+00:00","dateModified":"2024-09-23T11:22:46+00:00","mainEntityOfPage":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nieuwe-c-peptide-test-verlegt-de-tijdsgrenzen-van-mogelijke-behandeling\/"},"wordCount":143,"publisher":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#organization"},"articleSection":["Archief"],"inLanguage":"nl-NL"},{"@type":"WebPage","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nieuwe-c-peptide-test-verlegt-de-tijdsgrenzen-van-mogelijke-behandeling\/","url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nieuwe-c-peptide-test-verlegt-de-tijdsgrenzen-van-mogelijke-behandeling\/","name":"Nieuwe C-peptide test verandert idee van T1D - Breakthrough T1D","isPartOf":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#website"},"datePublished":"2012-02-26T09:00:00+00:00","dateModified":"2024-09-23T11:22:46+00:00","breadcrumb":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nieuwe-c-peptide-test-verlegt-de-tijdsgrenzen-van-mogelijke-behandeling\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/breakthrought1d.eu\/nl\/nieuws\/nieuwe-c-peptide-test-verlegt-de-tijdsgrenzen-van-mogelijke-behandeling\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/nieuwe-c-peptide-test-verlegt-de-tijdsgrenzen-van-mogelijke-behandeling\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/breakthrought1d.eu\/nl\/"},{"@type":"ListItem","position":2,"name":"Nieuwe C-peptide test verandert idee van T1D"}]},{"@type":"WebSite","@id":"https:\/\/breakthrought1d.eu\/nl\/#website","url":"https:\/\/breakthrought1d.eu\/nl\/","name":"Breakthrough T1D","description":"Wij zetten ons in voor een toekomst zonder T1D","publisher":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/breakthrought1d.eu\/nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/breakthrought1d.eu\/nl\/#organization","name":"Breakthrough T1D","url":"https:\/\/breakthrought1d.eu\/nl\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/","url":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png","contentUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png","width":330,"height":141,"caption":"Breakthrough T1D"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6","name":"ylt-admin","image":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","caption":"ylt-admin"},"sameAs":["https:\/\/87.250.144.92"],"url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/"}]}},"_links":{"self":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5597","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/comments?post=5597"}],"version-history":[{"count":1,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5597\/revisions"}],"predecessor-version":[{"id":7330,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5597\/revisions\/7330"}],"wp:attachment":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/media?parent=5597"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/categories?post=5597"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/tags?post=5597"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}